Markets mixed amid COVID-19 silver lining - Monday Review, February 22

Markets mixed amid COVID-19 silver lining - Monday Review, February 22

Investors cautious as significant economic and medical events took place

The US

Even though the number of COVID-19 infections continues to slow down, and vaccine rollouts gain pace, and a fiscal stimulus is expected to be approved, most markets closed in the red. USA30 rose 0.1%, while USA500 was down 0.77%. TECH100 dropped 2.46%.

Crude oil added 0.5% reaching $59.55 per barrel.

Gold rose 0.9% to $1,792.70 per ounce.

Asia and Australia

Markets were mostly up as the COVID-19 vaccines rollouts advance, and optimism grew for an economic recovery.

Japan225 jumped 0.26%.

HongKong45 inched up 0.05% as it received the first batch of Sinovac Biotech Ltd’s COVID-19 vaccine, and with the registration for priority groups set to open on Tuesday.

Down under, Australia200 edged down 0.14% after the country began its COVID-19 vaccine rollout and reported the third consecutive day with no new infection cases.

Europe

Stocks started the week cautiously, as investors focused on the vaccine rollouts and economic developments. Germany30 traded 1.3% lower. France40 and UK100 each dropped 1.1%.

Brent oil rose 0.6% to $62.53 a barrel.

EUR/USD traded 1.2102 after it lost 0.1%.

Sources: reuters.com, investing.com

This information prepared by za.capex.com is not an offer or a solicitation for the purpose of purchase or sale of any financial products referred to herein or to enter into any legal relations, nor an advice or a recommendation with respect to such financial products.

This information is prepared for general circulation. It does not regard to the specific investment objectives, financial situation or the particular needs of any recipient.

You should independently evaluate each financial product and consider the suitability of such a financial product, by taking into account your specific investment objectives, financial situation or particular needs, and by consulting an independent financial adviser as needed, before dealing in any financial products mentioned in this document.

This information may not be published, circulated, reproduced or distributed in whole or in part to any other person without the Company’s prior written consent. Past performance is not always indicative of likely or future performance. Any views or opinions presented are solely those of the author and do not necessarily represent those of za.capex.com

JME Financial Services (Pty) Ltd trading as ZA.CAPEX.COM acts as intermediary between the investor and Magnasale Trading Ltd, the counterparty to the contract for difference purchased by the Investor via ZA.CAPEX.COM, authorised & regulated by the Cyprus Securities and Exchange Commission with license number 264/15. Magnasale Trading Ltd is the principal to the CFD purchased by investors.